Welcome to our dedicated page for Meiwu Technology Company SEC filings (Ticker: WNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Meiwu Technology Company Limited's SEC filings document foreign private issuer reports on capital structure, material agreements, governance and interim financial disclosure. Recent Form 6-K reports cover securities purchase agreements, registered direct offerings, private placements, ordinary-share issuances, warrants and related restrictions on future equity activity.
The filings also report director and officer changes, unaudited condensed consolidated financial statements, management's discussion and analysis, and Nasdaq-listed ordinary share matters. Offering disclosures reference a shelf registration statement on Form F-3, prospectus supplement materials and warrant terms associated with the company's financing transactions.
Meiwu Technology Company Limited files an amended F-1 for a mixed offering registering 38,000,000 new ordinary shares and 12,000,000 shares for resale. The primary shares are offered on a best-efforts basis at a fixed price of $0.8 per share, with no minimum raise, while the company receives no proceeds from the selling shareholder’s 12,000,000 shares. Net primary proceeds are earmarked approximately 9.5% for online marketing of the “Gongfuzhiye (功肤之夜)” skincare brand, 28% to build over 1,500 offline affiliate stores, 12.5% for working capital, and 50% for bitcoin investments. Meiwu is a British Virgin Islands holding company whose operations are in China, so cash upstreaming depends on PRC rules and FX controls, and it highlights legal, regulatory, HFCAA and PRC policy risks, including the possibility of stricter oversight of China-based issuers. This amendment mainly adds unaudited financials for the six months ended June 30, 2025 and 2024 and updates certain exhibits.
Meiwu Technology Company Limited is filing a Form F-1 to register a mixed offering of up to 38,000,000 ordinary shares in a primary best-efforts offering at $0.8 per share and 12,000,000 ordinary shares for resale by its chairman, Changbin Xia. Meiwu will receive proceeds only from the primary sale and plans to allocate about 9.5% to online marketing for its “Gongfuzhiye (功肤之夜)” skincare brand, 28% to build over 1,500 offline affiliate stores, 12.5% for working capital, and approximately 50% for bitcoin investments. The company is a British Virgin Islands holding company whose operations are conducted through subsidiaries in China, and it highlights significant PRC regulatory, cash-transfer, dividend, HFCAA, and China-related policy risks, including the possibility that Chinese government actions could materially affect its operations and the value of its Nasdaq-listed shares.
Meiwu Technology Company Limited filed a Form 6-K as a foreign private issuer, mainly to share updated interim information with investors. The filing furnishes unaudited condensed consolidated financial statements and related notes for the six months ended June 30, 2025 and 2024, along with a management discussion and analysis of its financial condition and operating results.
Meiwu Technology Company Limited filed a Form S-8 to register 475,220 ordinary shares, no par value, issuable under its 2025 Equity Incentive Plan. The registration statement incorporates the company's Form 20-F and certain Form 6-K reports by reference and lists the 2025 Plan, counsel opinions, and consents as exhibits.
The document confirms the company is organized in the British Virgin Islands, identifies its principal office in Xiamen, China, and indicates the company is a non-accelerated filer and an emerging growth company. Plan documents required for recipients are to be provided separately and are not filed as part of Part I of the S-8.